Buspirone Hydrochloride → Buspirone

HRID 1402639

반응식

HRID 1402639 반응식
[CH:1]1[CH:2]=[N:3][C:4]([N:7]2[CH2:12][CH2:11][N:10]([CH2:13][CH2:14][CH2:15][CH2:16][N:17]3[C:27](=[O:28])[CH2:26][C:21]4([CH2:25][CH2:24][CH2:23][CH2:22]4)[CH2:20][C:18]3=[O:19])[CH2:9][CH2:8]2)=[N:5][CH:6]=1.Cl>CCO>[CH:1]1[CH:6]=[N:5][C:4]([N:7]2[CH2:12][CH2:11][N:10]([CH2:13][CH2:14][CH2:15][CH2:16][N:17]3[C:27](=[O:28])[CH2:26][C:21]4([CH2:22][CH2:23][CH2:24][CH2:25]4)[CH2:20][C:18]3=[O:19])[CH2:9][CH2:8]2)=[N:3][CH:2]=1

참가 물질

3

반응물 1

HCID 36431Buspirone Hydrochloride

생성물 1

HCID 2477Buspirone

시약·촉매·용매 1

HCID 702Ethanol용매

실험 절차

0.2 grams of Phospholipin 90 were dissolved in 2.5 grams EtOH; to this solution 0.02 grams of Vitamin E were added and mixed to obtain a clear system. To this system, 0.2 grams of buspirone HCl dissolved in 7.08 grams DDW were slowly added under constant stirring at room temperature in Heidolph mixer (700 rpm). The obtained system was stirred for additional 5 minutes.

후처리

  1. additionmixed
  2. customto obtain a clear system
  3. additionwere slowly added
  4. stirringThe obtained system was stirred for additional 5 minutes

출처 및 근거

ORD 기록
ord-bf8638285ae54532a2da69bf1f4e4edb
출처 데이터셋
uspto-grants-2014_12
특허 번호
US08911751B2

연결된 노트

불러오는 중…